跳至主要内容
临床试验/JPRN-UMIN000033150
JPRN-UMIN000033150招募中未知

Analysis of the efficacy of baricitinib in bone erosion assessed by HR-pQCT in rheumatoid arthritis. - Analysis of joint change using HR-pQCT in rheumatoid arthritis treated by baricitinib.

agasaki University Graduate School of Biomedical Sciences0 个研究点目标入组 42 人开始时间: 2018年6月26日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Pregnant patients 2.The patients who cannot rest the extremities during taking HR-pQCT. 3.The patients who is treated with prednisone >10mg 4.The patients who are taking intraarticular corticosteroid injection into evaluation joints within 6 months before enrollment. 5.The patients who are complicated with other disease which can affect evaluation joint. 6.In the opinion of the investigator, the patients who is not suitable for this study for other reasons.

研究者

发起方
agasaki University Graduate School of Biomedical Sciences

相似试验